U.K.

February 2, 2018February 2, 2018

MS Trust Seeking PPMS Patients’ Views on Ocrevus as It Tries to Obtain British Coverage

News

Britain’s Multiple Sclerosis Trust is asking patients to help them get the National Health Service to cover Ocrevus (ocrelizumab) as a treatment for primary progressive multiple sclerosis, or PPMS. The key ... Read more

January 26, 2018January 26, 2018

Brabio, 1st Generic Version of Copaxone for Relapsing MS, Launched in UK

News

Brabio (glatiramer acetate injection), the first generic alternative to Copaxone for relapsing multiple sclerosis (MS) patients, was recently launched in the U.K. at an equivalent higher dose, ... Read more

January 23, 2018January 22, 2018

Who Are You to Tell Me What MS Therapy I Need?

Columns, The MS Wire - A Column by Ed Tobias

I’m used to seeing insurance companies here in the United States make decisions about MS therapies, including refusing to pay for certain treatments unless other, less ... Read more

December 22, 2017December 22, 2017

Britain’s National Health Service Likely to Cover the Multiple Sclerosis Therapy Extavia

News

Britain’s National Health Service should cover the multiple sclerosis therapy Extavia, the National Institute for Health and Care Excellence (NICE) has recommended. The health service usually follows the institute’s ... Read more

July 21, 2017July 24, 2017

Do MS Patients in the UK Get the Right Treatment Quickly Enough?

Columns, The MS Wire - A Column by Ed Tobias

About two years ago, a report by the European Multiple Sclerosis Platform stated that only 21% of MS patients in the United Kingdom were receiving any ... Read more

June 12, 2017June 12, 2017

Maccabees Band Plans Charity Concert for the United Kingdom’s MS Society

News

The Maccabees rock band will play an exclusive gig in London to raise funds for the United Kingdom’s MS Society, supporting the organization’s mission of trying ... Read more

June 9, 2017June 9, 2017

MS Trust Project to Bring Needed Services to People with Advanced MS Wins October Club’s Support

News

The British fundraising group The October Club and The MS Trust, a U.K. multiple sclerosis research and support organization, have announced an ambitious plan to potentially help thousands of advanced MS patients in need ... Read more

June 8, 2017June 8, 2017

High-dose Simvastatin Improves Cognitive Function in MS, New Analysis of Trial Results Reports

News

A high daily dose of simvastatin improves multiple sclerosis patients’ cognitive function, according to a new analysis of Phase 2 clinical trial results. The British team that ... Read more

November 9, 2016November 9, 2016

UK Announces New Employment Support Package for Health-Disabled People

News

The British government announced on Oct. 31 that a new Personal Support Package will be available for people with health disabilities, such as multiple sclerosis (MS), ... Read more

October 13, 2016October 13, 2016

Heparin for MD Myelin Repair to Be Studied in United Kingdom

News

The MS Society in the United Kingdom is funding a new project at the University of Glasgow, in Scotland, to examine if  heparin, a drug widely used for ... Read more

September 7, 2016December 15, 2016

James Received HSCT for Free, as He Lives in the UK

Columns, What's Important Now -- An MS Column by Ian Franks

Virtually all the talk about availability of HSCT1 as an MS treatment includes the need to travel long distances to other countries, but U.K. residents can ... Read more

March 22, 2016March 22, 2016

Ethnic Study of East Londoners with MS Highlights Role of Environment in Disease Onset

News

According to new research published in the Multiple Sclerosis Journal, environmental factors appear to play a much greater role in the onset of multiple sclerosis (MS) than ... Read more

November 12, 2015November 12, 2015

Vitally Important UK MS Services Face Critical Challenges According to Study

News

A major new report published by the U.K. MS Trust has determined that the country’s National Health Services (NHS) programs relied on by people living with ... Read more